Tenaya Therapeutics (TNYA) Treasury Shares (2020 - 2026)
Tenaya Therapeutics (TNYA) posted quarterly Treasury Shares of $2.5 million for Q1 2026, up 10.85% year-over-year from $2.3 million in Q1 2025, and up 63.9% quarter-over-quarter from $1.5 million in Q4 2025.
Tenaya Therapeutics (TNYA) Treasury Shares (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Treasury Shares history runs 7 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- In Q1 2026, Treasury Shares rose 10.85% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (up 10.85% YoY), while the FY2025 annual figure was $1.5 million, up 13.44% from the prior year.
- Treasury Shares for Q1 2026 stood at $2.5 million, up from $1.5 million in the prior quarter.
- The five-year high for Treasury Shares was $2.5 million in Q1 2026, with the low at $61537.0 in Q3 2022.
- The 5-year median for Treasury Shares is $1.4 million (2024), against an average of $1.3 million.
- The sharpest annual moves came in 2022 and 2023: Treasury Shares plunged 99.72% in 2022, then soared 1763.53% in 2023.
- Tenaya Therapeutics' Treasury Shares stood at $459192.0 in 2022, then surged by 137.0% to $1.1 million in 2023, then rose by 24.43% to $1.4 million in 2024, then increased by 13.44% to $1.5 million in 2025, then surged by 63.9% to $2.5 million in 2026.
- Business Quant data shows TNYA's Treasury Shares at $2.5 million in Q1 2026, $1.5 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Tenaya Therapeutics | 151.50 Mn | 151.50 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.21 Mn |
| Jun 30, 2026 | 2.21 Mn |
| Mar 31, 2026 | 2.52 Mn |
| Mar 31, 2026 | 2.52 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 2.27 Mn |
| Mar 31, 2025 | 2.27 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.55 Mn |
| Sep 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 1.62 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Mar 31, 2024 | 1.73 Mn |